Showing results (141-150 of 831) with videos related to

Sort By:
Pageof 84
Cancer|March 13, 2010
Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrenceStefan Faderl, Alessandra Ferrajoli, William Wierda, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Approaches to Chronic Lymphocytic Leukemia Therapy in the Era of New Agents: The Conundrum of Many OptionsNitin Jain, Philip Thompson, Alessandra Ferrajoli, et al.
Leukemia Research|August 4, 2009
Fludarabine, cyclophosphamide, mitoxantrone plus rituximab (FCM-R) in frontline CLL <70 YearsStefan Faderl, William Wierda, Susan O'Brien, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 28, 2026
Chronic Lymphocytic Leukemia Through the Spectrum: Frontline Therapy, Sequencing With Subsequent Therapy, and Treatment of Double-Refractory PatientsAnna Maria Frustaci, Alessandra Tedeschi, Alexander F Vom Stein, et al.
Cancer|April 14, 2007
Current and emerging treatment options in chronic myeloid leukemiaElias Jabbour, Jorge E Cortes, Francis J Giles, et al.
Cancer|August 23, 2008
Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemiaSusan O'Brien, Deborah A Thomas, Farhad Ravandi, et al.
American Journal of Hematology|March 26, 2016
Analysis of racial variations in disease characteristics, treatment patterns, and outcomes of patients with chronic lymphocytic leukemiaChadi Nabhan, Kari G Chaffee, Susan L Slager, et al.
Clinical Proteomics|May 8, 2026
Proteomic and phosphoproteomic signatures of disease progression in unmutated IGHV chronic lymphocytic leukemiaRenee C Tschumper, Neil E Kay, Sameer A Parikh, et al.
Blood|July 8, 2010
Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switchWei Ding, Traci R Knox, Renee C Tschumper, et al.
Cancer|May 13, 2004
Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in Richter syndromeApostolia-Maria Tsimberidou, James L Murray, Susan O'Brien, et al.
Pageof 84